Species-dependent enantioselective glucuronidation of carprofen

Xenobiotica

Volumn 28, Issue 6, 1998, Pages 595-604

  Maire Gauthier, R ^a   Buronfosse, T ^a   Magdalou, J ^b   Herber, R ^c   Besse, S ^a   Delatour, P ^a   Benoit, E ^a  

^a VETAGRO SUP   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c Centre du Medicament URA CNRS 597   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARPROFEN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG GLUCURONIDATION; DRUG HYDROLYSIS; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME KINETICS; LIVER MICROSOME; MALE; NONHUMAN; RAT; STEREOCHEMISTRY;

ANIMALIA; CANIS FAMILIARIS; EQUUS CABALLUS; OVIS ARIES;

EID: 0031800890     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982598239344     Document Type: Article

References (27)

1. BRADFORD, M. M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-254.
2. DELATOUR, P., BENOIT, E., BOURDIN, M., GOBRON, M. and MOYSAN F., 1993, Enantiosélectivité comparée de la disposition du kétoprofène et du carprofène chez l'homme et l'animal. Bulletin de l'Académie Nationale de Médecine, 177, 515-527.
3. DELATOUR, P., GARNIER, F. and MAIRE, R., 1996, Enantiosélectivité de l'excrétion des glucuronides du carprofène chez l'homme, le chien et le cheval. Bulletin de l'Académie Nationale de Médecine, 180, 1565-1572.
4. DRAGACCI, S., THOMASSIN, J., MAGDALOU, J., SOUHAILI EL AMRI, H., BOISSEL, P. and SIEST, G., 1987, Properties of human hepatic UDP-glucuronosyltransferases. Relationship to other inductible enzymes in patients with cholestasis. European Journal of Clinical Pharmacology, 32, 485-491.
5. EBNER, T. and BURCHELL, B., 1993, Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of UGT1 gene family. Drug Metabolism and Disposition, 21, 50-55.
6. EL MOUELHI, M., RUELIUS, H. W., FENSELAU, C. and DULIK, D. M., 1987, Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids: naproxen, ibuprofen and benoxaprofen. Drug Metabolism and Disposition, 15, 767-772.
7. FOURNEL-GIGLEUX, S., HAMAR-HANSEN, C., MOTASSIM, N., ANTOINE, B., MOTHE, O., DECOLIN, D., CALDWELL, J. and SIEST, G., 1988, Substrate specificity and enantioselectivity of arylcarboxylic acid glucuronidation. Drug Metabolism and Disposition, 16, 627-634.
8. GAUT, Z. N., BARUTH, H., RANDALL, L. O., ASHLEY, C. and PAULSRUD, J. R., 1975, Stereoisomeric relationships among anti-inflammatory' activity, inhibition of platelet aggregation and inhibition of prostaglandin synthetase. Prostaglandins, 10, 59-66.
9. GRASER, T. A., JORDAN, J.-C., KARPF, M. and HOLCK, M., 1991, Determination of carprofen enantiomers: application to biological fluids of target species. Acta Veterinaria Scandinavica, 87, 247-248.
10. HAMDOUNE, M., MOUNIE, J., MAGDALOU, J., MASMOUDI, T., GOUDOUNET, H. and ESCOUSSE A., 1995, Characterization of the in vitro glucuronidation of flurbiprofen enantiomers. Drug Metabolism and Disposition, 23, 343-348.
11. IWAKAWA, S., SPAHN, H., BENET, L. Z. and LIN, E. T., 1990, Stereoselective binding of the glucuronide conjugates of carprofen enantiomers to human serum albumin. Biochemical Pharmacology, 39, 949-953.
12. IWAKAWA, S., SPAHN, H., BENET, L. Z. and LIN, E. T., 1991, Stereoselective disposition of carprofen, flunoxaprofen, and naproxen in rats. Drug Metabolism and Disposition, 19, 853-857.
13. IWAKAWA, S., SUGANUMA, T., LEE, S.-F., SPAHN, H., BENET, L. Z. and LIN, E. T., 1989, Direct determination of diastereomeric carprofen glucuronides in human plasma and urine and preliminary measurements of stereoselective metabolic and renal elimination after oral administration of carprofen in man. Drug Metabolism and Disposition, 17, 414-419.
14. JIN, C., MINERS, J. O., LILLYWHITE, K.J. and MACKENZIE, P. I., 1993, Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. Journal of Pharmacology and Experimental Therapeutics, 264, 475-479.
15. KEMMERER, J. M., RUBIO, F. A., MCCLAIN, R. M. and KOECHLIN, B. A., 1979, Stereospecific assay and stereospecific disposition of racemic carprofen in rats. Journal of Pharmaceutical Sciences, 68, 1274-1280.
16. LEES, P., DELATOUR, P., BENOIT, E. and FOSTER, A. P., 1991, Pharmacokinetics of carprofen enantiomers in the horse. Acta Veterinaria Scandinavica, 87, 249-251.
17. MCKELLAR, Q. A., DELATOUR, P. and LEES, P., 1994, Stereospecific pharmacodynamics and pharmacokinetics of carprofen in the dog. Journal of Veterinary Pharmacology and Therapeutics, 17, 447-454.
18. PRITCHARD, M., FOURNEL-GIGLEUX, S., SIEST, G., MACKENZIE, P. I. and MAGDALOU, J., 1994, A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2Bl) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids. Molecular Pharmacology, 45, 42-50.
19. RAHMAN, M. H., MARUYAMA, T., OKADA, T., TERUKO, I. and OTAGIRI, M., 1993, Study of the interaction of carprofen and its enantiomers with human serum albumin - II. Stereoselectivite site-to-site displacement of carprofen by ibuprofen. Biochemical Pharmacology, 46, 1733-1740.
20. RAY, J. E. and WADE, D. N., 1982, The pharmacokinetics and metabolism of 14C-carprofen in man. Biopharmaceutics and Drug Disposition, 3, 29-38.
21. RUBIO, F., SEAWALL, S., POCELINKO, R., DE BARBIERI, B., BENZ, W., BERGER, L., MORGAN, L., PAO, J., WILLIAMS, T. H. and KOECHLIN, B., 1980, Metabolism of carprofen, a non-steroidal antiinflammatory agent, in rats, dogs, and humans. Journal of Pharmaceutical Sciences, 69, 1245-1253.
22. SORACI, A., BENOIT, E., JAUSSAUD, P., LEES, P. and DELATOUR, P., 1995, Enantioselective glucuronidation and subsequent biliary excretion of carprofen in horses. American Journal of Veterinary Research, 56, 358-361.
23. SPAHN, H., IWAKAWA, S., LIN, E. T. and BENET, L. Z., 1989, Procedures to characterize in vivo and in vitro enantioselective glucuronidation properly: studies with benoxaprofen glucuronides. Pharmaceutical Research, 6, 125-132.
24. SPAHN, H., SPAHN, I., PFLUGMANN, G., MUTSCHLER, E. and BENET, L. Z., 1988, Measurement of carprofen enantiomer concentrations in plasma and urine using L-leucinamide as the chiral coupling component. Journal of Chromatography, 433, 331-338.
25. STOLTENBORG, J. K., PUGLISI, C. V., RUBIO, F. and VANE, F. M., 1981, High-performance liquid chromatographic determination of stereoselective disposition of carprofen in humans. Journal of Pharmaceutical Sciences, 70, 1207-1212.
26. SWEENY, D. J. and NELLANS, H. N., 1995, Stereoselective glucuronidation of zileuton isomers by human hepatic microsomes. Drug Metabolism and Disposition, 23, 149-153.
27. VOLLAND, C. and BENET, L. Z., 1991, In vitro enantioselective glucuronidation of fenoprofen. Pharmacology, 43, 53-60.